Palliation of hepatic tumors

被引:41
作者
Cunningham, Steven C. [2 ]
Choti, Michael A. [1 ]
Bellavance, Emily C. [2 ]
Pawlik, Timothy M. [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21287 USA
[2] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA
来源
SURGICAL ONCOLOGY-OXFORD | 2007年 / 16卷 / 04期
关键词
palliation; hepatic tumors; symptom relief; interventions;
D O I
10.1016/j.suronc.2007.08.010
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Palliation is treatment aimed at alleviating the symptomatic effects of a disease rather than at curing the disease. The four most common types of Liver tumors that often require palliative treatment include hepatocellular carcinoma (HCC), cholangiocarcinoma (CC), metastatic colorectal carcinoma (mCRC), and metastatic neuroendocrine tumors (mNET). Modalities employed in the palliative treatment of these tumors most often include resection, stenting, chemotherapy, radiation, ablation, and the general treatment of Liver failure symptoms. Many of these modalities can be applied to the palliative care of all hepatic tumor types, regardless of the specific tumor histology-as incurable cancers often converge along a final common pathway. We herein provide a review of the therapeutic approaches to palliate hepatic tumors, as well as how such therapies are designed to alleviate the symptoms of patients with end-stage liver tumors. (C) 2007 Elsevier Ltd. ALL rights reserved.
引用
收藏
页码:277 / 291
页数:15
相关论文
共 171 条
[1]  
ACKERMAN NB, 1974, SURGERY, V75, P589
[2]   ISLET CELL TUMORS METASTATIC TO THE LIVER - EFFECTIVE PALLIATION BY SEQUENTIAL HEPATIC-ARTERY EMBOLIZATION [J].
AJANI, JA ;
CARRASCO, CH ;
CHARNSANGAVEJ, C ;
SAMAAN, NA ;
LEVIN, B ;
WALLACE, S .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (03) :340-344
[3]  
Altendorf-Hofmann Annelore, 2003, Surg Oncol Clin N Am, V12, P165, DOI 10.1016/S1055-3207(02)00091-1
[4]   Chemotherapy [J].
Arnold, R ;
Rinke, A ;
Schmidt, C .
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY, 2005, 19 (04) :649-656
[5]  
Belli Giulio, 2002, J Hepatobiliary Pancreat Surg, V9, P607, DOI 10.1007/s005340200082
[6]   Phase II trial of high-dose conformal radiation therapy with concurrent hepatic artery floxuridine for unresectable intrahepatic malignancies [J].
Ben-Josef, E ;
Normalle, D ;
Ensminger, WD ;
Walker, S ;
Tatro, D ;
Ten Haken, RK ;
Knol, J ;
Dawson, LA ;
Pan, C ;
Lawrence, TS .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (34) :8739-8747
[7]   Laparoscopic radiofrequency ablation of neuroendocrine liver metastases [J].
Berber, E ;
Flesher, N ;
Siperstein, AE .
WORLD JOURNAL OF SURGERY, 2002, 26 (08) :985-990
[8]   Medical palliation of the jaundiced patient with pruritus [J].
Bergasa, NV .
GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2006, 35 (01) :113-+
[9]   Hepatocellular carcinoma [J].
Bergsland, EK ;
Venook, AP .
CURRENT OPINION IN ONCOLOGY, 2000, 12 (04) :357-361
[10]   Photodynamic therapy for advanced bile duct cancer:: Evidence for improved palliation and extended survival [J].
Berr, F ;
Wiedmann, M ;
Tannapfel, A ;
Halm, U ;
Kohlhaw, KR ;
Schmidt, F ;
Wittekind, C ;
Hauss, J ;
Mössner, J .
HEPATOLOGY, 2000, 31 (02) :291-298